Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders

Journal of Steroid Biochemistry and Molecular Biology

Volumn 143, Issue , 2014, Pages 460-472

  Yang, Song Yu ^a,c   He, Xue Ying ^a   Isaacs, Charles ^a   Dobkin, Carl ^a,c   Miller, David ^a   Philipp, Manfred ^b,c  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

ABAD; Alzheimer'; Developmental intellectual disabilities; HSD17B10 gene; Metabolism of allopregnanolone; Mitochondria; Multifunctional protein; Neuroactive steroids; s disease

Indexed keywords

17BETA HYDROXYSTEROID DEHYDROGENASE TYPE 10; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ALCOHOL DEHYDROGENASE; CYTOCHROME C; ISOLEUCINE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; 3 (OR 17)-BETA-HYDROXYSTEROID DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE;

ALZHEIMER DISEASE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CEREBROSPINAL FLUID; COMPETITIVE INHIBITION; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; GENE; HOMEOSTASIS; MISSENSE MUTATION; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; REVIEW; ANIMAL; ENZYMOLOGY; HUMAN; METABOLISM; PATHOLOGY;

17-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; HUMANS; MICE; NEURODEGENERATIVE DISEASES;

EID: 84904635377     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.07.001     Document Type: Review

References (105)

1. S.Y. Yang, X.Y. He, and D. Miller HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids Mol. Genet. Metab. 92 2007 36 42 (Pubitemid 47361893)
2. X.Y. He, H. Schulz, and S.Y. Yang A human brain l-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in Alzheimer's disease J. Biol. Chem. 273 1998 10741 10746 (Pubitemid 28227690)
3. C.R. Kissinger, P.A. Rejto, L.A. Pelletier, J.A. Thomson, R.E. Showalter, M.A. Abreo, C.S. Agree, S. Margosiak, J.J. Meng, R.M. Aust, D. Vanderpool, B. Li, A. Tempczyk-Russell, and J.E. Villafranca Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics J. Mol. Biol. 342 2004 943 952 (Pubitemid 39165660)
4. X.Y. He, G. Merz, P. Mehta, H. Schulz, and S.Y. Yang Human brain short chain l-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase J. Biol. Chem. 274 1999 15014 15019
5. X.Y. He, Y.Z. Yang, H. Schulz, and S.Y. Yang Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain l-3-hydroxyacyl-CoA dehydrogenase Biochem. J. 345 Pt 1 2000 139 143 (Pubitemid 30060114)
6. S.D. Yan, Y. Shi, A. Zhu, J. Fu, H. Zhu, Y. Zhu, L. Gibson, E. Stern, K. Collison, F. Al-Mohanna, S. Ogawa, A. Roher, S.G. Clarke, and D.M. Stern Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity J. Biol. Chem. 274 1999 2145 2156
7. S.Y. Yang, X.Y. He, and H. Schulz 3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease FEBS J. 272 2005 4874 4883 (Pubitemid 41415112)
8. S.Y. Yang, X.Y. He, S.E. Olpin, V.R. Sutton, J. McMenamin, M. Philipp, R.B. Denman, and M. Malik Mental retardation linked to mutations in the HSD17B10 gene interfering with neurosteroid and isoleucine metabolism Proc. Natl. Acad. Sci. U. S. A. 106 2009 14820 14824
9. A.J. Powell, J.A. Read, M.J. Banfield, F. Gunn-Moore, S.D. Yan, J. Lustbader, A.R. Stern, D.M. Stern, and R.L. Brady Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD) J. Mol. Biol. 303 2000 311 327
10. S.Y. Yang, X.Y. He, and H. Schulz Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase Trends Endocrinol. Metab. 16 2005 167 175 (Pubitemid 40603096)
11. N. Shafqat, H.U. Marschall, C. Filling, E. Nordling, X.Q. Wu, L. Bjork, J. Thyberg, E. Martensson, S. Salim, H. Jornvall, and U. Oppermann Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/ 17beta/20beta/21-HSD Biochem. J. 376 2003 49 60 (Pubitemid 37492899)
12. X.Y. He, J. Wegiel, Y.Z. Yang, R. Pullarkat, H. Schulz, and S.Y. Yang Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of gamma-aminobutyric acid type A receptors Mol. Cell. Endocrinol. 229 2005 111 117 (Pubitemid 40018089)
13. X.Y. He, and S.Y. Yang Roles of type 10 17beta-hydroxysteroid dehydrogenase in intracrinology and metabolism of isoleucine and fatty acids Endocr. Metab. Immune Disord. Drug Targets 6 2006 95 102
14. K.E. Muirhead, M. Froemming, X. Li, K. Musilek, S.J. Conway, D. Sames, and F.J. Gunn-Moore (-)-CHANA, a fluorogenic probe for detecting amyloid binding alcohol dehydrogenase HSD10 activity in living cells ACS Chem. Biol. 5 2010 1105 1114
15. X.Y. He, G. Merz, Y.Z. Yang, R. Pullakart, P. Mehta, H. Schulz, and S.Y. Yang Function of human brain short chain l-3-hydroxyacyl coenzyme A dehydrogenase in androgen metabolism Biochim. Biophys. Acta 1484 2000 267 277 (Pubitemid 30175975)
16. G. Moeller, and J. Adamski Integrated view on 17beta-hydroxysteroid dehydrogenases Mol. Cell. Endocrinol. 301 2009 7 19
17. S. Marchais-Oberwinkler, C. Henn, G. Moller, T. Klein, M. Negri, A. Oster, A. Spadaro, R. Werth, M. Wetzel, K. Xu, M. Frotscher, R.W. Hartmann, and J. Adamski 17beta-Hydroxysteroid dehydrogenases (17beta-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development J. Steroid Biochem. Mol. Biol. 125 2011 66 82
18. X.Y. He, G. Merz, Y.Z. Yang, P. Mehta, H. Schulz, and S.Y. Yang Characterization and localization of human type10 17beta-hydroxysteroid dehydrogenase Eur. J. Biochem. 268 2001 4899 4907 (Pubitemid 32953806)
19. S.Y. Yang, and X.Y. He Role of type 10 17beta-hydroxysteroid dehydrogenase in the pathogenesis of Alzheimer's disease Adv. Exp. Med. Biol. 487 2001 101 110
20. J. Holzmann, P. Frank, E. Loffler, K.L. Bennett, C. Gerner, and W. Rossmanith RNase P without RNA: identification and functional reconstitution of the human mitochondrial tRNA processing enzyme Cell 135 2008 462 474
21. V. Jazbutyte, F. Kehl, L. Neyses, and T. Pelzer Estrogen receptor alpha interacts with 17beta-hydroxysteroid dehydrogenase type 10 in mitochondria Biochem. Biophys. Res. Commun. 384 2009 450 454
22. U.C. Oppermann, S. Salim, L.O. Tjernberg, L. Terenius, and H. Jornvall Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease FEBS Lett. 451 1999 238 242 (Pubitemid 29243784)
23. S.D. Yan, J. Fu, C. Soto, X. Chen, H. Zhu, F. Al-Mohanna, K. Collison, A. Zhu, E. Stern, T. Saido, M. Tohyama, S. Ogawa, A. Roher, and D. Stern An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease Nature 389 1997 689 695 (Pubitemid 27458947)
24. K. Beyreuther, and C.L. Masters Alzheimer's disease. The ins and outs of amyloid-beta Nature 389 1997 677 678 (Pubitemid 27458939)
25. X.Y. He, G. Merz, C.H. Chu, D. Lin, Y.Z. Yang, P. Mehta, H. Schulz, and S.Y. Yang Molecular cloning, modeling, and localization of rat type 10 17beta-hydroxysteroid dehydrogenase Mol. Cell. Endocrinol. 171 2001 89 98 (Pubitemid 32098202)
26. X.Y. He, G.Y. Wen, G. Merz, D. Lin, Y.Z. Yang, P. Mehta, H. Schulz, and S.Y. Yang Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model Brain Res. Mol. Brain Res. 99 2002 46 53 (Pubitemid 34178500)
27. S.D. Yan, Y. Zhu, E.D. Stern, Y.C. Hwang, O. Hori, S. Ogawa, M.P. Frosch, E.S. Connolly Jr., R. McTaggert, D.J. Pinsky, S. Clarke, D.M. Stern, and R. Ramasamy Amyloid beta -peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress J. Biol. Chem. 275 2000 27100 27109
28. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan, and H. Wu ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452 (Pubitemid 38495942)
29. X.Y. He, C. Dobkin, and S.Y. Yang Does the HSD17B10 gene escape from X-inactivation? Eur. J. Hum. Genet. 19 2011 123 124
30. S.Y. Yang, X.Y. He, and D. Miller Hydroxysteroid (17beta) dehydrogenase X in human health and disease Mol. Cell. Endocrinol. 343 2011 1 6
31. J. Zschocke, J.P. Ruiter, J. Brand, M. Lindner, G.F. Hoffmann, R.J. Wanders, and E. Mayatepek Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism Pediatr. Res. 48 2000 852 855
32. S.Y. Yang, C. Dobkin, X.Y. He, M. Philipp, and W.T. Brown A 5-methylcytosine hotspot responsible for the prevalent HSD17B10 mutation Gene 515 2013 380 384
33. J. Garcia-Villoria, A. Navarro-Sastre, C. Fons, C. Perez-Cerda, A. Baldellou, M.A. Fuentes-Castello, I. Gonzalez, A. Hernandez-Gonzalez, C. Fernandez, J. Campistol, C. Delpiccolo, N. Cortes, A. Messeguer, P. Briones, and A. Ribes Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: difficulties in the diagnosis Clin. Biochem. 42 2009 27 33
34. L.H. Seaver, X.Y. He, K. Abe, T. Cowan, G.M. Enns, L. Sweetman, M. Philipp, S. Lee, M. Malik, and S.Y. Yang A novel mutation in the HSD17B10 gene of a 10-year-old boy with refractory epilepsy, choreoathetosis and learning disability PLoS One 6 2011 e27348
35. R. Ofman, J.P. Ruiter, M. Feenstra, M. Duran, B.T.J. Poll-The Zschocke, R. Ensenauer, W. Lehnert, J.O. Sass, W. Sperl, and R.J. Wanders 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene Am. J. Hum. Genet. 72 2003 1300 1307 (Pubitemid 36530018)
36. M.R. Cazorla, A. Verdu, C. Perez-Cerda, and A. Ribes Neuroimage findings in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency Pediatr. Neurol. 36 2007 264 267 (Pubitemid 46601346)
37. C. Perez-Cerda, J. Garcia-Villoria, R. Ofman, P.R. Sala, B. Merinero, J. Ramos, M.T. Garcia-Silva, B. Beseler, J. Dalmau, R.J. Wanders, M. Ugarte, and A. Ribes 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease Pediatr. Res. 58 2005 488 491 (Pubitemid 41254512)
38. K. Rauschenberger, K. Scholer, J.O. Sass, S. Sauer, Z. Djuric, C. Rumig, N.I. Wolf, J.G. Okun, S. Kolker, H. Schwarz, C. Fischer, B. Grziwa, H. Runz, A. Numann, N. Shafqat, K.L. Kavanagh, G. Hammerling, R.J. Wanders, J.P. Shield, U. Wendel, D. Stern, P. Nawroth, G.F. Hoffmann, C.R. Bartram, B. Arnold, A. Bierhaus, U. Oppermann, H. Steinbeisser, and J. Zschocke A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival EMBO Mol. Med. 2 2010 51 62
39. S.Y. Yang, X.Y. He, C. Dobkin, C. Issacs, and W.T. Brown V.R. Preedy, R. Rajendram, V.B. Patel, Mental Retardation and Isoleucine Metabolism, Branched-Chain Amino Acids in Health and Disease 2014 Springer New York
40. C. Lenski, R.F. Kooy, E. Reyniers, D. Loessner, R.J. Wanders, B. Winnepenninckx, H. Hellebrand, S. Engert, C.E. Schwartz, A. Meindl, and J. Ramser The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior Am. J. Hum. Genet. 80 2007 372 377 (Pubitemid 46175685)
41. E. Reyniers, P. Van Bogaert, N. Peeters, L. Vits, F. Pauly, E. Fransen, N. Van Regemorter, and R.F. Kooy A new neurological syndrome with mental retardation, choreoathetosis, and abnormal behavior maps to chromosome Xp11 Am. J. Hum. Genet. 65 1999 1406 1412 (Pubitemid 30460392)
42. J. Zschocke HSD10 disease: clinical consequences of mutations in the HSD17B10 gene J. Inherit. Metab. Dis. 35 2012 81 89
43. R.C. Melcangi, and G.C. Panzica Allopregnanolone: state of the art Prog. Neurobiol. 113 2014 1 5
44. S. Luchetti, I. Huitinga, and D.F. Swaab Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis Neuroscience 191 2011 6 21
45. A.M. Hosie, M.E. Wilkins, H.M. da Silva, and T.G. Smart Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites Nature 444 2006 486 489 (Pubitemid 44809065)
46. J.W. Trauger, A. Jiang, B.A. Stearns, and P.V. LoGrasso Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2) Biochemistry 41 2002 13451 13459 (Pubitemid 35303905)
47. C.J. Hedeskov, K. Capito, and P. Thams Cytosolic ratios of free [NADPH]/[NADP+] and [NADH]/[NAD+] in mouse pancreatic islets, and nutrient-induced insulin secretion Biochem. J. 241 1987 161 167 (Pubitemid 17004725)
48. X.Y. He, J. Wegiel, and S.Y. Yang Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase Brain Res. 1040 2005 29 35 (Pubitemid 40459618)
49. D. Maric, Q.Y. Liu, I. Maric, S. Chaudry, Y.H. Chang, S.V. Smith, W. Sieghart, J.M. Fritschy, and J.L. Barker GABA expression dominates neuronal lineage progression in the embryonic rat neocortex and facilitates neurite outgrowth via GABA(A) autoreceptor/Cl- channels J. Neurosci. 21 2001 2343 2360 (Pubitemid 32240532)
50. C. Ortez, C. Villar, C. Fons, S.T. Duarte, A. Perez, J. Garcia-Villoria, A. Ribes, A. Ormazabal, M. Casado, J. Campistol, M.A. Vilaseca, and A. Garcia-Cazorla Undetectable levels of CSF amyloid-beta peptide in a patient with 17beta-hydroxysteroid dehydrogenase deficiency J. Alzheimers Dis. 27 2011 253 257
51. X.Y. He, D. Miller, and S.Y. Yang Possible alteration of amyloid-beta protein precursor metabolism or trafficking in a 17beta-hydroxysteroid dehydrogenase X deficiency patient J. Alzheimer's Dis. 2011 http://j-alz.com/ letteresditor/index.html#December2011
52. M. Windholz The Merk Index 10th ed. 1983 Merk & Co., Inc. Rahway, NJ 970
53. S.H. Korman, and S.Y. Yang HSD17B10 replaces HADH2 as the approved designation for the gene mutated in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency Mol. Genet. Metab. 91 2007 115 (Pubitemid 46550921)
54. I.H. Segel Enzyme Kinetics Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems 1993 Wiley-Interscience New York
55. X. Chen, and S.D. Yan Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease IUBMB Life 58 2006 686 694 (Pubitemid 46895569)
56. K.E. Muirhead, E. Borger, L. Aitken, S.J. Conway, and F.J. Gunn-Moore The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease Biochem. J. 426 2010 255 270
57. K. Takuma, J. Yao, J. Huang, H. Xu, X. Chen, J. Luddy, A.C. Trillat, D.M. Stern, O. Arancio, and S.S. Yan ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction FASEB J. 19 2005 597 598 (Pubitemid 40471256)
58. S.D. Yan, and D.M. Stern Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD) Int. J. Exp. Pathol. 86 2005 161 171 (Pubitemid 40813912)
59. E. Fukuzaki, K. Takuma, Y. Funatsu, Y. Himeno, Y. Kitahara, B. Gu, H. Mizoguchi, D. Ibi, K. Koike, M. Inoue, S.D. Yan, and K. Yamada Ovariectomy increases neuronal amyloid-beta binding alcohol dehydrogenase level in the mouse hippocampus Neurochem. Int. 52 2008 1358 1364
60. E. Borger, L. Aitken, K.E. Muirhead, Z.E. Allen, J.A. Ainge, S.J. Conway, and F.J. Gunn-Moore Mitochondrial beta-amyloid in Alzheimer's disease Biochem. Soc. Trans. 39 2011 868 873
61. J. Yao, H. Du, S. Yan, F. Fang, C. Wang, L.F. Lue, L. Guo, D. Chen, D.M. Stern, F.J. Gunn Moore, J. Xi Chen, O. Arancio, and S.S. Yan Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease J. Neurosci. 31 2011 2313 2320
62. E. Borger, L. Aitken, H. Du, W. Zhang, F.J. Gunn-Moore, and S.S. Yan Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease? Curr. Alzheimer Res. 10 2013 21 29
63. K.R. Valasani, G. Hu, M.O. Chaney, and S.S. Yan Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Abeta for treatment of Alzheimer's disease Chem. Biol. Drug Des. 81 2013 238 249
64. K. Kuwabara, M. Matsumoto, J. Ikeda, O. Hori, S. Ogawa, Y. Maeda, K. Kitagawa, N. Imuta, T. Kinoshita, D.M. Stern, H. Yanagi, and T. Kamada Purification and characterization of a novel stress protein, the 150-kDa oxygen-regulated protein (ORP150), from cultured rat astrocytes and its expression in ischemic mouse brain J. Biol. Chem. 271 1996 5025 5032
65. X. Wang, R. Sato, M.S. Brown, X. Hua, and J.L. Goldstein SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis Cell 77 1994 53 62
66. A.T. Marques, A. Antunes, P.A. Fernandes, and M.J. Ramos Comparative evolutionary genomics of the HADH2 gene encoding Abeta-binding alcohol dehydrogenase/17beta-hydroxysteroid dehydrogenase type 10 (ABAD/HSD10) BMC Genomics 7 2006 202
67. L. Torroja, D. Ortuno-Sahagun, A. Ferrus, B. Hammerle, and J.A. Barbas scully, an essential gene of Drosophila, is homologous to mammalian mitochondrial type II l-3-hydroxyacyl-CoA dehydrogenase/amyloid-beta peptide-binding protein J. Cell Biol. 141 1998 1009 1017 (Pubitemid 28243967)
68. Z. Kristofikova, M. Bockova, K. Hegnerova, A. Bartos, J. Klaschka, J. Ricny, D. Ripova, and J. Homola Enhanced levels of mitochondrial enzyme 17beta-hydroxysteroid dehydrogenase type 10 in patients with Alzheimer disease and multiple sclerosis Mol. Biosyst. 5 2009 1174 1179
69. Y. Yan, Y. Liu, M. Sorci, G. Belfort, J.W. Lustbader, S.S. Yan, and C. Wang Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction Biochemistry 46 2007 1724 1731
70. X.Y. He, and S.Y. Yang 3-hydroxyacyl-CoA dehydrogenase (HAD) deficiency replaces short-chain hydroxyacyl-CoA dehydrogenase (SCHAD) deficiency as well as medium- and short-chain hydroxyacyl-CoA dehydrogenase (M/SCHAD) deficiency as the consensus name of this fatty acid oxidation disorder Mol. Genet. Metab. 91 2007 205 206
71. X.Y. He, Y.X. Yang, and S.Y. Yang Changes of the HSD17B10 gene expression levels in ulcerative colitis Inflamm. Bowel Dis. 19 2013 E23 E24
72. Y. Xu, H. Li, Y.H. Jin, J. Fan, and F. Sun Dimerization interface of 3-hydroxyacyl-CoA dehydrogenase tunes the formation of its catalytic intermediate PLoS One 9 2014 e95965
73. X. Liu, G. Deng, X. Chu, N. Li, L. Wu, and D. Li Formation of an enolate intermediate is required for the reaction catalyzed by 3-hydroxyacyl-CoA dehydrogenase Bioorg. Med. Chem. Lett. 17 2007 3187 3190 (Pubitemid 46702609)
74. S.Y. Yang, and X.Y. He Re: Hadh2 and 3-hydroxyacyl-CoA dehydrogenase Am. J. Physiol. Endocrinol. Metab. 295 2008 E987
75. D.H. Silverman, G.W. Small, C.Y. Chang, C.S. Lu, M.A. Kung De Aburto, W. Chen, J. Czernin, S.I. Rapoport, P. Pietrini, G.E. Alexander, M.B. Schapiro, W.J. Jagust, J.M. Hoffman, K.A. Welsh-Bohmer, A. Alavi, C.M. Clark, E. Salmon, M.J. de Leon, R. Mielke, J.L. Cummings, A.P. Kowell, S.S. Gambhir, C.K. Hoh, and M.E. Phelps Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome JAMA 286 2001 2120 2127 (Pubitemid 34041597)
76. D. Green, A.R. Marks, S. Fleischer, and J.O. McIntyre Wild type and mutant human heart (R)-3-hydroxybutyrate dehydrogenase expressed in insect cells Biochemistry 35 1996 8158 8165 (Pubitemid 26234915)
77. A.A. Morris Cerebral ketone body metabolism J. Inherit. Metab. Dis. 28 2005 109 121 (Pubitemid 40723878)
78. Y. Murakami, I. Ohsawa, T. Kasahara, and S. Ohta Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde Neurobiol. Aging 30 2009 325 329
79. P.H. Reddy, R. Tripathi, Q. Troung, K. Tirumala, T.P. Reddy, V. Anekonda, U.P. Shirendeb, M.J. Calkins, A.P. Reddy, P. Mao, and M. Manczak Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics Biochim. Biophys. Acta 1822 2012 639 649
80. S. DiMauro, and E.A. Schon Mitochondrial disorders in the nervous system Annu. Rev. Neurosci. 31 2008 91 123
81. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 2006 787 795 (Pubitemid 44622683)
82. D. Pratico, K. Uryu, S. Leight, J.Q. Trojanoswki, and V.M. Lee Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J. Neurosci. 21 2001 4183 4187 (Pubitemid 32538543)
83. I. Sayeed, S. Parvez, B. Wali, D. Siemen, and D.G. Stein Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone Brain Res. 1263 2009 165 173
84. X. Wang, B. Su, S.L. Siedlak, P.I. Moreira, H. Fujioka, Y. Wang, G. Casadesus, and X. Zhu Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins Proc. Natl. Acad. Sci. U. S. A. 105 2008 19318 19323
85. M. Picard, and B.S. McEwen Mitochondria impact brain function and cognition Proc. Natl. Acad. Sci. U. S. A. 111 2014 7 8
86. Y. Hara, F. Yuk, R. Puri, W.G. Janssen, P.R. Rapp, and J.H. Morrison Presynaptic mitochondrial morphology in monkey prefrontal cortex correlates with working memory and is improved with estrogen treatment Proc. Natl. Acad. Sci. U. S. A. 111 2014 486 491
87. K. Tieu, C. Perier, M. Vila, C. Caspersen, H.P. Zhang, P. Teismann, V. Jackson-Lewis, D.M. Stern, S.D. Yan, and S. Przedborski l-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease Ann. Neurol. 56 2004 51 60 (Pubitemid 38857359)
88. Y.A. Lim, A. Grimm, M. Giese, A.G. Mensah-Nyagan, J.E. Villafranca, L.M. Ittner, A. Eckert, and J. Gotz Inhibition of the mitochondrial enzyme ABAD restores the amyloid-beta-mediated deregulation of estradiol PLoS One 6 2011 e28887
89. V. De Preter, I. Arijs, K. Windey, W. Vanhove, S. Vermeire, F. Schuit, P. Rutgeerts, and K. Verbeke Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway Inflamm. Bowel Dis. 18 2012 1127 1136
90. M. Rotinen, J. Villar, J. Celay, and I. Encio Type 10 17beta-hydroxysteroid dehydrogenase expression is regulated by C/EBPbeta in HepG2 cells J. Steroid Biochem. Mol. Biol. 122 2010 164 171
91. S.Y. Yang, C. Dobkin, X.Y. He, and W.T. Brown Transcription start sites and epigenetic analysis of the HSD17B10 proximal promoter BMC Biochem. 14 2013 17
92. J. Yao, M. Taylor, F. Davey, Y. Ren, J. Aiton, P. Coote, F. Fang, J.X. Chen, S.D. Yan, and F.J. Gunn-Moore Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model Mol. Cell. Neurosci. 35 2007 377 382 (Pubitemid 46843572)
93. Y. Ren, H.W. Xu, F. Davey, M. Taylor, J. Aiton, P. Coote, F. Fang, J. Yao, D. Chen, J.X. Chen, S.D. Yan, and F.J. Gunn-Moore Endophilin I expression is increased in the brains of Alzheimer disease patients J. Biol. Chem. 283 2008 5685 5691
94. E. Vilardo, and W. Rossmanith The amyloid-beta-SDR5C1(ABAD) interaction does not mediate a specific inhibition of mitochondrial RNase P PLoS One 8 2013 e65609
95. A. Falkevall, N. Alikhani, S. Bhushan, P.F. Pavlov, K. Busch, K.A. Johnson, T. Eneqvist, L. Tjernberg, M. Ankarcrona, and E. Glaser Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP J. Biol. Chem. 281 2006 29096 29104 (Pubitemid 44507053)
96. S. Vepsalainen, M. Hiltunen, S. Helisalmi, J. Wang, T. van Groen, H. Tanila, and H. Soininen Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology Neurosci. Lett. 438 2008 216 220
97. A.M. Barron, and C.J. Pike Sex hormones, aging, and Alzheimer's disease Front Biosci. (Elite Ed) 4 2012 976 997
98. D.B. Dubal, M.E. Wilson, and P.M. Wise Estradiol: a protective and trophic factor in the brain J. Alzheimers Dis. 1 1999 265 274
99. B.S. McEwen, K.T. Akama, J.L. Spencer-Segal, T.A. Milner, and E.M. Waters Estrogen effects on the brain: actions beyond the hypothalamus via novel mechanisms Behav. Neurosci. 126 2012 4 16
100. L.D. Griffin, W. Gong, L. Verot, and S.H. Mellon Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone Nat. Med. 10 2004 704 711 (Pubitemid 38937635)
101. J.M. Wang, C. Singh, L. Liu, R.W. Irwin, S. Chen, E.J. Chung, R.F. Thompson, and R.D. Brinton Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 107 2010 6498 6503
102. C.E. Marx, W.T. Trost, L.J. Shampine, R.D. Stevens, C.M. Hulette, D.C. Steffens, J.F. Ervin, M.I. Butterfield, D.G. Blazer, M.W. Massing, and J.A. Lieberman The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease Biol. Psychiatry 60 2006 1287 1294 (Pubitemid 44838538)
103. D. Ayan, R. Maltais, and D. Poirier Identification of a 17beta-hydroxysteroid dehydrogenase type 10 steroidal inhibitor: a tool to investigate the role of type 10 in Alzheimer's disease and prostate cancer ChemMedChem 7 2012 1181 1184
104. O.A. Mamer, S.S. Tjoa, C.R. Scriver, and G.A. Klassen Demonstration of a new mammalian isoleucine catabolic pathway yielding an R series of metabolites Biochem. J. 160 1976 417 426
105. J. Vidugiriene, and A.K. Menon Early lipid intermediates in glycosyl-phosphatidylinositol anchor assembly are synthesized in the ER and located in the cytoplasmic leaflet of the ER membrane bilayer J. Cell Biol. 121 1993 987 996 (Pubitemid 23154260)